41 / 62
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 1, January/February 2020
AFRICA
39
14. Roberts P, Adwani S, Archer N, Wilson N. Catheter closure of the arte-
rial duct in preterm infants.
Arch Dis Child Fetal Neonatal Ed
2007;
92
:
F248–F250.
15. Prada FH, Carretero JM, Jimenez L. Percutaneous closure of a patent
arterial duct in a newborn.
Cardiol Young
2009;
19
(4): 400–4002.
16. Núñez FR, Álvarez AA, José Trisac JLF, Pardeiro CA. Percutaneous
closure of patent ductus arteriosus in preterm infants.
Rev Esp Cardiol
2010;
63
(6): 740–50.
17. Prsa M, Ewert P. Transcatheter closure of a patent ductus arteriosus in
a preterm infant with an Amplatzer vascular plug IV device.
Catheter
Cardiovasc Interv
2011;
77
: 108–111.
18. Kang SL, Jivanji S, Mehta C, Tometzki AJ, Derrick G, Yates R,
et al
.
Outcome after transcatheter occlusion of patent ductus arteriosus in
infants less than 6 kg: A national study from United Kingdom and
Ireland
. Catheter Cardiovasc Interv
2017;
90
(7): 1135–1144.
19. Kenny D, Morgan GJ, Bentham JR, Wilson N, Martin R, Tometzki
A,
et al
. Early clinical experience with a modified Amplatzer ductal
occluder for transcatheter arterial duct occlusion in infants and small
children.
Catheter Cardiovasc Interv
2013;
82
: 534–540.
20. Kudo Y, Suda K, Yoshimoto H, Teramachi Y, Kishimoto S, Lemura
M,
et al
. Trans-pulmonary echocardiography as a guide for device
closure of patent ductus arteriosus.
Catheter Cardiovasc Interv
2015;
86
: 264–270.
21. Baspinar O, Irdem A, Sivasli E, Sahin DA, Kilinc M. Comparison of
the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS)
in children weighing less than 10 kg.
Pediatr Cardiol
2013;
34
(1): 88–94.
22. Sungur M, Karakurt C, Ozbarlas N, Baspinar O. Closure of patent
ductus arteriosus in children, small infants, and premature babies with
Amplatzer duct occluder II additional sizes: multicenter study.
Catheter
Cardiovasc Interv
2013;
82
(2): 245–252.
23. Pavlek LR, Slaughter JL, Berman DP, Backes CH. Catheter-based
closure of the patent ductus arteriosus in lower weight infants.
Seminars
Perinatal
2018;
43
: 262–268.
24. Hoffman JI. The global burden of congenital heart disease.
Cardiovasc
J Africa
2013;
24
(4): 141.
25. Hoosen EG, Cilliers AM, Hugo-Hamman CT, Brown SC, Lawrenson
JB, Zuhlke L,
et al
. Paediatric cardiac services in South Africa.
S Afr
Med J
2011;
101
(2): 106–107.
26. Nguyen N, Leon-Wyss J, Iyer KS, Pezzella AT. Paediatric cardiac
surgery in low-income and middle-income countries: a continuing chal-
lenge.
Arch Dis Child
2015;
100
(12): 1156–1159.
27. Evans N. Diagnosis of patent ductus arteriosus in the preterm newborn.
Arch Dis Child
1993;
68
: 58–61.
28. Van der Laan ME, Roofthooft MT, Fries MW, Berger RM, Schat TE,
van Zoonen AG,
et al
. A hemodynamically significant patent ductus
arteriosus does not affect cerebral or renal tissue oxygenation in preterm
infants.
Neonatology
2016;
110
(2): 141–147.
29. The Task Force for the Diagnosis and Treatment of Pulmonary
Hypertension of the European Society of Cardiology (ESC) and the
European Respiratory Society (ERS), endorsed by the International
Society of Heart and Lung Transplantation (ISHLT). Guidelines for the
diagnosis and treatment of pulmonary hypertension.
Eur Heart J
2009;
30
: 2493–2537.
30. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L. Severity
of the ductal shunt: a comparison of different markers.
Arch Dis Child
Fetal Neonatal Ed
2005;
90
: F419–422.
31. Baruteau AE, Hascoët S, Baruteau J, Boudjemline Y, Lambert V, Angel
CY,
et al
. Transcatheter closure of patent ductus arteriosus: past, present
and future.
Arch Cardiovasc Dis
2014;
107
(2): 122–132.
32. De Maria C, Di Pietro L, Lantada AD, Madete J, Makobore PN,
Mridha M,
et al
. Safe innovation: On medical device legislation in
Europe and Africa.
Health Policy Technol
2018;
7
(2): 156–165.
33. Krichenko A, Benson LN, Burrows P, Moes CAF, McLaughlin P,
Freedom RM. Angiographic classification of the isolated, persistently
patent ductus arteriosus and implications for percutaneous catheter
occlusion.
Am J Cardiol
1989;
63
: 877–880.
34. Bergersen L, Marshall A, Gauvreau K, Beekman R, Hirsch R, Foerster
S,
et al
. Adverse event rates in congenital cardiac catheterization – a
multi-center experience.
Catheter Cardiovasc Interv
2010;
75
: 389–400.
35. Kobayashi D, Meadows J, Forbes TJ, Moore P, Javois AJ, Pedra CA,
et
al
. Standardizing radiation dose reporting in the pediatric cardiac cath-
eterization laboratory – a multicenter study by the CCISC (Congenital
Cardiovascular Interventional Study Consortium).
Catheter Cardiovasc
Interv
2014;
84
(5): 785–793.
36. Al-lawama M, Alammori I, Abdelghani T, Badran E. Oral paracetamol
versus oral ibuprofen for treatment of patent ductus arteriosus.
J Int
Med Res
2018;
46
(2): 811–818.
37. Sathanandam S, Justino H, Waller BR, Radtke W, Qureshi AM. Initial
clinical experience with the Medtronic micro vascular plug™ in tran-
scatheter occlusion of PDAs in extremely premature infants.
Catheter
Cardiovasc Interv
2017;
89
(6): 1051–1058.
38. Zahn EM, Nevin P, Simmons C, Garg R. A novel technique for tran-
scatheter patent ductus arteriosus closure in extremely preterm infants
using commercially available technology.
Catheter Cardiovasc Interv
2015;
85
(2): 240–248.
39. Gross AA, Donnelly JP. Closure of tubular patent ductus arteriosus in
infants with the Amplatzer vascular plug II.
Catheter Cardiovasc Interv
2013;
81
(7): 1188–1193.
40. Kobayashi D, Sallaam S, Aggarwal S, Singh HR, Turner DR, Forbes
TJ,
et al
. Catheterization‐based intervention in low birth weight infants
less than 2.5 kg with acute and long‐term outcome.
Catheter Cardiovasc
Interv
2013;
82
(5): 802–810.
41. Philip R, Rush Waller B, Agrawal V, Wright D, Arevalo A, Zurakowski
D,
et al
. Morphologic characterization of the patent ductus arteriosus
in the premature infant and the choice of transcatheter occlusion device.
Catheter Cardiovasc Interv
2016;
87
(2): 310–317.
42. Rodríguez Ogando A, Planelles Asensio I, de la Blanca ARS,
et al
.
Surgical ligation versus percutaneous closure of patent ductus arteriosus
in very low-weight preterm infants: which are the real benefits of the
percutaneous approach?
Pediatr Cardiol
2018;
39
(2): 398–410.